<DOC>
	<DOCNO>NCT01202552</DOCNO>
	<brief_summary>One-site dose spar intradermal influenza vaccination elderly study result unsatisfactory outcome . The investigator evaluate safety immunogenicity two-site intradermal injection influenza vaccine contain 6 12 microgram hemagglutinin antigen per strain ( 4/10th 8/10th regular 15 microgram HA/strain intramuscular vaccine respectively ) elderly 60 year age . An influenza vaccine administer intramuscularly standard dose use reference vaccine .</brief_summary>
	<brief_title>Two-site Intradermal Influenza Vaccination Elderly</brief_title>
	<detailed_description>The subject would randomly divide three group 60 subject . Group1 receive single intramuscular dose 0.5 ml trivalent influenza vaccine , contain least 15 microgram hemagglutinin antigen per strain , Group II receive two-site intradermal dose 0.1 ml , contain least 3 microgram hemagglutinin antigen per strain per site group III receive two-site intradermal dose 0.2 ml , contain least 6 microgram hemagglutinin antigen per strain per site . Check HA Antibody</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Hemagglutinins</mesh_term>
	<criteria>healthy male female volunteer age least 60 year old willing participate study previous influenza vaccination within 6 month systemic ypersensitivity egg chicken proteins vaccine component history lifethreatening reaction study vaccine vaccine contain constituent . ongoing acute febrile illness ( oral temperature , â‰¥37.5 c ) congenital acquire immunodeficiency treatment immunosuppressive immune modify drug cancer therapy within previous 6 month longterm treatment systemic corticosteroid receipt blood bloodderived product previous 3 month history thrombocytopenia bleed disorder contraindicate intramuscular vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>influenza</keyword>
	<keyword>age</keyword>
	<keyword>intradermal injection</keyword>
</DOC>